{{Rsnum
|rsid=12582168
|Gene=NCOR2
|Chromosome=12
|position=124409638
|Orientation=plus
|GMAF=0.2668
|Gene_s=NCOR2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.3 | 33.3 | 63.3
| HCB | 6.7 | 51.1 | 42.2
| JPT | 16.3 | 34.9 | 48.8
| YRI | 10.3 | 39.7 | 50.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 6.7 | 51.1 | 42.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=9E-6
  |OR=1.45
  |ORtxt=[1.21-1.748]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}